Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 281 - 300 of 469
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2023, 4:02 am by Berniard Law Firm
In October, 2014 Jenkins filed a lawsuit for damages against Bristol-Myers Squibb Company and Otsuka American Pharmaceutical Inc., the makers of Abilify. [read post]
15 Dec 2011, 9:00 pm by Stephanie Figueroa
The new venture is in collaboration with Bristol-Myers Squibb, DuPont and Pfizer. [read post]
26 Mar 2021, 5:56 pm by Sean Wajert
What is of particular interest to our readers is the Court’s re-emphasis of the meaning of Bristol-Myers Squibb Co. v. [read post]
12 Jun 2013, 12:50 pm by Tom Lamb
The concerns relate to a number of widely prescribed GLP-1–based therapies, the 2 injectable GLP-1 agonists, exenatide (Byetta, Amylin/Lilly) and liraglutide (Victoza, Novo Nordisk), and the oral DPP-4 inhibitors sitagliptin, saxagliptin (Ongylza, AstraZeneca/Bristol-Myers Squibb), and linagliptin (Tradjenta, Boehringer Ingelheim/Lilly). [read post]
7 Dec 2009, 2:12 am by Kevin LaCroix
Most notably, the parties to the Bristol- Myers Squibb securities class action lawsuit agreed to settle that case for $300 million while the case was on appeal to the Third Circuit following the district court’s dismissal. [read post]
9 Mar 2009, 4:44 am
Those companies surveyed by Towers Perrin are: Merck, Abbott Laboratories, Amgen, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-LaRoche, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth.You'll notice that list contains 14 companies â€â [read post]
9 Nov 2007, 9:03 am
  In turn, GlaxoSmithKline could follow the lead of Bristol-Myers Squibb (BMS) when that drug company experienced increasing scrutiny about the safety of its antibiotic Tequin in 2006. [read post]
24 Jan 2013, 11:49 am by Bexis
Bristol-Myers Squibb Co., No. 06-6050 (FLW) (D.N.J. [read post]
9 Nov 2015, 3:55 am by Broc Romanek
Would be used much more than XBRL…” Webcast: “How to Draft Meaningful Sustainability Reports” Tune in tomorrow for the webcast – “How to Draft Meaningful Sustainability Reports” – to hear Lou Coppola of the Governance & Accountability Institute, Kate Kelly of Bristol-Myers Squibb and Pam Styles of Next Level Investor Relations explain the keys to drafting sustainability reports that are meaningful to investors &… [read post]
10 Nov 2015, 3:41 am by Broc Romanek
Don’t forget to tune in today for the webcast – “How to Draft Meaningful Sustainability Reports” – to hear Lou Coppola of the Governance & Accountability Institute, Kate Kelly of Bristol-Myers Squibb and Pam Styles of Next Level Investor Relations explain the keys to drafting sustainability reports that are meaningful to investors & other constituents and a “how to” list of things you should be aware of when drafting. [read post]
27 Nov 2017, 12:53 pm by Eric B. LaPre, Muhammad U. Faridi
The shareholder alleged that the defendant corporation, Bristol-Myers Squibb, and members of its board of directors, failed to monitor the company’s compliance with the Foreign Corrupt Practices Act (“FCPA”), leading to a $14.7 million settlement with the Securities and Exchange Commission. [read post]
9 Jan 2009, 10:56 am
" For 2009, Davis also refiled proposals seeking more disclosure about executive compensation (at Bristol-Myers Squibb, Comcast, and Con Edison) and to prohibit stock options, at Continental Airlines, Pfizer, and Verizon. [read post]
21 Apr 2016, 7:35 am by Devika Agarwal
The first application pertained to Bristol-Myers Squibb’s cancer drug, Dastanib, which was filed by Indian generic drug manufacturer, BDR Pharma. [read post]
25 Jan 2019, 12:00 am by David Lopez
The first being Bristol Myers Squibb Co’s (BMY) acquisition of Celgene Corp. [read post]
30 Nov 2010, 8:57 am by Sonya Hubbard
Prior to working for Bill Gates, she worked for a variety of companies including Bristol-Myers Squibb Company, PepsiCo, Inc., Enron Corporation, pcOrder.com, Inc., and Trilogy Inc. [read post]
4 Sep 2012, 7:31 am by arester
Skadden, Arps, Slate, Meagher & Flom LLP was hired by Amylin to perform delicate corporate surgery, first extracting the diabetes-drug developer—along with, Bydureon, its most valuable drug—from a soured pact with Eli Lilly & Co. and then helping to sell the company to Bristol-Myers Squibb Co. in a $5.1 billion deal that closed in August... [read post]
26 Feb 2013, 9:02 am by Pilar G. Kraman
On the agenda: • Two keynote addresses by USPTO’s Teresa Stanek Rea and WIPO’s James Pooley • AIA and NPEs: one year on • Lessons from Canadian reforms • Monetization of patents: strategies for deriving maximum value from your patent portfolio • Life sciences & ITC industries focus • Doing business in China: how to ensure your patented assets in China are making you money Speakers: • James Pooley, deputy director general for innovation and… [read post]
6 Jan 2007, 7:34 am
  The key ingredient in the breast cancer drug Taxol owned by Bristol-Myers Squibb Co. is taken from the bark of the yew tree, and Wyeth's kidney transplant drug Rapamune comes from Easter Island soil," according to the article's author, Rick Veccio. [read post]